New York, NY -- (ReleaseWire) -- 11/19/2012 --Cannabis Science Inc. (PINK:CBIS) serves in medical marijuana industry. The company offers its services related to the variety of products derived from cannabis. Its stock closed its latest trading session at $0.09, up 2.33 percent from its previous close of $0.99, with very high volumes.
The stock opened the session at $0.09 and touched its highest price point at $0.10. Cannabis Science stock’s lowest price point for the session stood at $0.09. The stock’s MACD chart shows bullish trend and the stock may test its first support level at $0.07.
Find out when could be the best moment to trade CBIS by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=CBIS
Nestle (PINK:NSRGY) reported that its unit Nespresso USA will open its first West Coast coffee bar in San Francisco. The bar is likely to be opened this month. The company stock traded in the range of $61.50 and $62.00 during its latest trading session.
The stock had opened at $61.89 and closed at $61.98, down 0.75 percent from its previous close of $62.45. The stock is currently trading below its 6 days EMA and 20 days EMA prices and thus showing bearish trend. The stock may go as low as $60.94 level in the coming trading sessions. Nestle’s second support level is at $60.36.
Get all the fundamental tips on when to trade NSRGY by getting the full trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=NSRGY
Amarantus BioSciences Inc. (OTC:AMBS) announced that it is scheduled to make a presentation at CNS Summit 2012. The company also announced securing $1.1 million in financing. However, the stock closed its latest trading session at $0.04, down 12.77 percent from its previous close of $0.05.
The stock shows neutral trend as it made the up move with high trading volume. Its neutral trend is further confirmed by its MACD chart and the stock may go as low as $0.03 in its coming trading sessions. Upon breaching this level, the stock may fall down to $0.02. Amarantus BioSciences is a development stage company and is based out of California.
Find out more about AMBS by reading the full trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=AMBS
Hemp Inc. (PINK:HEMP) opened at $0.06 and closed at $0.062, up 6.90 percent from its previous close. It is currently trading above its 10 days moving average of 0.06 and has its first resistance level at $0.09. In the intermediate time period, the stock may test $0.05 support level.
The company offers its services in medical marijuana industry. It is currently working on building a website for providing information about marijunana. It is also engaged in the development of nutraceutical products. The company was formed in 2008 and it is based out of Nevada. Hemp Inc. was earlier known as Marijuana Inc.
Get all the traders are looking for when trading HEMP here: http://www.wallstreetreport.net/market-scan/?symbol=HEMP
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
Alexander K. Neumann
WALL STREET REPORT